Cognitive Training Intervention and Attitudes Towards Genetics

Description

A pilot study to evaluate feasibility of enrollment of patients in an intervention to improve neurocognitive function in hematopoietic cell transplantation (HCT) survivors using the cognitive training Lumosity program. In addition, patients' interest in receiving information regarding genetic risk of cognitive impairment post-HCT will be measured.

Conditions

Cognitive Impairment, Hematologic Neoplasms, Hematopoietic Cell Transplant

Study Overview

Study Details

Study overview

A pilot study to evaluate feasibility of enrollment of patients in an intervention to improve neurocognitive function in hematopoietic cell transplantation (HCT) survivors using the cognitive training Lumosity program. In addition, patients' interest in receiving information regarding genetic risk of cognitive impairment post-HCT will be measured.

Intervention Strategies to Improve Cognitive Functioning in Hematologic Cancer Survivors After Hematopoietic Cell Transplantation

Cognitive Training Intervention and Attitudes Towards Genetics

Condition
Cognitive Impairment
Intervention / Treatment

-

Contacts and Locations

Birmingham

University of Alabama at Birmingham, Birmingham, Alabama, United States, 35233

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * ≥ 21 years old at time of allogeneic HCT performed at UAB
  • * Outpatient and between 3 and 6 months post HCT
  • * English speaking
  • * Possess access to an internet-connected home computer
  • * History of pre-existing neurological disorder or documented major psychiatric disorder; significant auditory, visual, or motor impairments
  • * Participated in neuropsychological intervention within the past 6 months
  • * History of color blindness

Ages Eligible for Study

21 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Alabama at Birmingham,

Noha M Sharafeldin, PRINCIPAL_INVESTIGATOR, University of Alabama at Birmingham

Study Record Dates

2025-07